Alexis Reisin Miller, JD, senior director, global regulatory policy and intelligence, Global Regulatory Affairs, Eisai Inc.
Alexis Reisin Miller is senior director, regulatory policy and intelligence at Eisai Inc. Miller is a member of Eisai’s Global Regulatory Affairs unit, and works with the Public Policy, Development, Commercial, Government Affairs, Legal, and other departments on a variety of regulatory and policy matters ranging from premarket (product creation and development) through commercialization. Through the commenting process, presenting and attending conferences, participating in working groups, and other outreach activities (e.g., working with industry organizations, FDA, and external colleagues), she contributes to regulatory policy dialogue as it evolves, with the ultimate goal of helping to shape the regulatory environment.
Prior to joining Eisai, Miller worked for several years in the Washington, DC, FDA regulatory practice group at the law firm, Morgan Lewis, both as an associate and as a partner. While at Morgan Lewis, Alexis advised a range of biopharmaceutical industry clients on regulatory, legal, and commercial issues arising throughout the product lifecycle. Before joining Morgan Lewis as a partner, Miller served as regulatory counsel in the Office of Regulatory Policy at FDA’s Center for Drug Evaluation and Research. Miller obtained her Juris Doctor from the Catholic University of America in Washington, DC, and her undergraduate degree from New York University.